A c c e p t e d M a n u s c r i p t 2 Dear Editor, We read with great interest the study and commentary regarding rapid molecular diagnostic (RMD) techniques with antimicrobial stewardship (AMS) support [1, 2] . Both manuscripts caution that single center studies are limited by local resistance rates. Previous single center studies of RMD, specifically matrix assisted laser deionization time of flight mass spectrometry (MALDI-TOF) demonstrated improved clinical and fiscal outcomes [3] [4] [5] . These results, which have become the norm in published MALDI-TOF studies, were conducted in locations with higher antibiotic resistance rates. Our retrospective study assessing MALDI-TOF implementation with AMS intervention in a healthcare system with relatively low antibiotic resistance rates are discordant with those presented [6] .
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Our primary analysis was time to susceptible antibiotic administration from phlebotomy, before and after MALDI-TOF implementation. All results were reported to the AMS pharmacist in an 18 hour window. Secondary outcomes included time to final identification, time to de-escalation, length of hospital stay, and 30-day all-cause mortality. During a two month period adult patients with bacteremia were included if they were admitted to the intensive care, hematology, or transplant units. A subset analysis in ICU patients was completed with corollary comparators. Patients with clinically identified bacterial contaminants were excluded. Antibiotic de-escalation was defined as appropriate narrowing of antibiotic spectrum following microbiologic laboratory updates. Continuous variables were evaluated with a two-tailed unpaired t-test, and categorical variables with Fisher's Exact.
There was no difference before (n=47) and after (n=49) MALDI-TOF implementation for time to Our study unfortunately did not demonstrate improved clinical outcomes found previously [3, 4] . 
